Document Detail


Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis.
MedLine Citation:
PMID:  16963174     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess the effect of a new progestin progestogen only pill (desogestrel) versus an oral contraceptive in the treatment of recurrent endometriosis. STUDY DESIGN: A randomized prospective clinical study. A group of women with endometriosis (n=40) who showed recurrent dysmenorrhea and/or pelvic pain after conservative surgery, and did not desire a pregnancy. Continuous treatment for 6 months with desogestrel (75 microg/d) (n=20) versus a combined oral contraceptive (ethinyl estradiol 20 microg plus desogestrel 150 microg) (n=20) was performed. RESULTS: A significant improvement of both pelvic pain and dysmenorrhea was observed following each type of treatment (P<0.001). The use of desogestrel progestogen only pill was associated with a breakthrough bleeding in 20% patients, while a significant body weight increase was observed in 15% after oral contraceptive. CONCLUSIONS: Both desogestrel and an oral estro-progestinic were effective, safe and low cost therapy of pain symptoms after endoscopic surgery for endometriosis, the former showing an impact on breakthrough bleeding, the later an incidence on body weight increase.
Authors:
Sandro Razzi; Stefano Luisi; Caterina Ferretti; Francesco Calonaci; Massimo Gabbanini; Massimo Mazzini; Felice Petraglia
Related Documents :
1837554 - Hysteroscopic gamete intra-fallopian transfer: a good alternative, in selected cases, t...
15118634 - Long-term follow-up after conservative surgery for rectovaginal endometriosis.
8329644 - Changing trends in treatment of leiomyomata uteri.
17377194 - Uterine artery embolization: a treatment option for symptomatic fibroids in postmenopau...
21706214 - Single-center clinical comparison of two reinforced ureteral access sheaths for retrogr...
10540994 - Clinical and functional outcome after anatomic and nonanatomic ankle ligament reconstru...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2006-09-11
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  135     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-12-06     Completed Date:  2008-03-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  188-90     Citation Subset:  IM    
Affiliation:
Chair of Obstetrics and Gynecology, Department of Pediatric, Obstetrics and Reproductive Medicine, University of Siena, Policlinico Le Scotte, 53100 Siena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Desogestrel / therapeutic use*
Endometriosis / blood,  drug therapy*,  surgery
Ethinyl Estradiol / therapeutic use*
Female
Humans
Metrorrhagia / drug therapy,  etiology
Pelvic Pain / drug therapy*
Progestins / therapeutic use*
Weight Gain / drug effects
Chemical
Reg. No./Substance:
0/Progestins; 54024-22-5/Desogestrel; 57-63-6/Ethinyl Estradiol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of naltrexone administration on dehydroepiandrosterone sulfate levels in male and female p...
Next Document:  Identifying crop vulnerability to groundwater abstraction: modelling and expert knowledge in a GIS.